Skip to main content

SG Americas Securities, LLC

SEC CIK
0001313360
Latest filing
Aug 7, 2026

IMVT holding history

Immunovant, Inc. in every 13F filed by SG Americas Securities, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IMVT overviewAll 13F holders of IMVTFull Q2 2026 holdings

Shares (Q2 2026)
24,920
Value
$960.0K
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of IMVT by SG Americas Securities, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202624,920$960.0K<0.1%+2,119+9.3%AddedHolders
Q1 202622,801$566.0K<0.1%−22,847−50.1%ReducedHolders
Q4 202545,648$1.16M<0.1%−16,950−27.1%ReducedHolders
Q3 202562,598$1.01M<0.1%+54,570+679.7%AddedHolders
Q2 20258,028$128.0K<0.1%+8,028NewHolders
Q4 20240$00.0%−15,944−100.0%Sold outHolders
Q3 202415,944$455.0K<0.1%−14,758−48.1%ReducedHolders
Q2 202430,702$811.0K<0.1%+26,546+638.7%AddedHolders
Q1 20244,156$134.0K<0.1%−25,781−86.1%ReducedHolders
Q4 202329,937$1.26M<0.1%−66,766−69.0%ReducedHolders
Q3 202396,703$3.71M<0.1%+50,795+110.6%AddedHolders
Q2 202345,908$871.0K<0.1%+13,208+40.4%AddedHolders
Q1 202332,700$507.0K<0.1%+11,673+55.5%AddedHolders
Q4 202221,027$373.0K<0.1%+4,323+25.9%AddedHolders
Q3 202216,704$93.0K<0.1%−5,918−26.2%ReducedHolders
Q2 202222,622$88.0K<0.1%+22,622NewHolders
Q1 20220$00.0%−15,032−100.0%Sold outHolders
Q4 202115,032$128.0K<0.1%−12,717−45.8%ReducedHolders
Q3 202127,749$241.0K<0.1%+27,749NewHolders
Q2 20210$00.0%−90,479−100.0%Sold outHolders
Q1 202190,479$1.45M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.